Availability of Medications for the Treatment of Opioid Use Disorder Among Pregnant and Postpartum Individuals in US Jails
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2021.44369
Abstract: Key Points Question What is the availability of medications for opioid use disorder (MOUD) for pregnant people in US jails? Findings In this cross-sectional study of 836 survey respondents from jails across the US, respondents… read more here.
Keywords: opioid use; availability medications; use disorder; treatment opioid ... See more keywords
Evaluation of the Effects of a Monthly Buprenorphine Depot Subcutaneous Injection on QT Interval During Treatment for Opioid Use Disorder
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Pharmacology and Therapeutics"
DOI: 10.1002/cpt.1406
Abstract: Extensive 12‐lead electrocardiogram monitoring and drug concentrations were obtained during development of BUP‐XR, a monthly subcutaneous injection for the treatment of opioid use disorder (OUD). Matched QT and plasma drug concentrations (11,925) from 1,114 subjects… read more here.
Keywords: use disorder; opioid use; subcutaneous injection; treatment opioid ... See more keywords
Effectiveness of treatment for opioid use disorder: A national, five-year, prospective, observational study in England.
Sign Up to like & getrecommendations! Published in 2017 at "Drug and alcohol dependence"
DOI: 10.1016/j.drugalcdep.2017.03.013
Abstract: BACKGROUND This the first 5-year effectiveness study of publicly funded treatment for opioid use disorder (OUD) in England. METHODS All adults initiating treatment in 2008/09 in all 149 local treatment systems reporting to the National… read more here.
Keywords: treatment; opioid use; treatment opioid; study ... See more keywords
Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade?
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Substance Abuse Treatment"
DOI: 10.1016/j.jsat.2020.108196
Abstract: The temporary loosening of regulations governing methadone and buprenorphine treatment for opioid use disorder (OUD) in the U.S., instituted to prevent the spread of COVID-19, has created an opportunity to explore the effectiveness of new… read more here.
Keywords: treatment; opioid use; treatment opioid; opioid cascade ... See more keywords
A bridge too far? Distance to waivered physicians and utilization of buprenorphine treatment for opioid use disorder in West Virginia Medicaid.
Sign Up to like & getrecommendations! Published in 2022 at "Substance abuse"
DOI: 10.1080/08897077.2021.1986882
Abstract: Background: Travel distance to medication treatment for opioid use disorder (OUD) is a challenge for many patients, but little is known about how distance is associated with medication treatment utilization. This study examines the association… read more here.
Keywords: buprenorphine treatment; opioid use; distance; treatment ... See more keywords
Addressing Workforce Needs for Medication Treatment of Opioid Use Disorder.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Addiction Medicine"
DOI: 10.1097/adm.0000000000000442
Abstract: : Medication treatment of opioid use disorder (OUD) is recognized as an effective evidence-based treatment. It has been underused, in part due to challenges in recruiting and retaining a provider workforce that is able to… read more here.
Keywords: use disorder; medication treatment; treatment; opioid use ... See more keywords
The Impact of Individual Counseling on Treatment for Opioid Use
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Addictions Nursing"
DOI: 10.1097/jan.0000000000000494
Abstract: Abstract In 2018, more than 67,000 people died because of drug overdoses, and of that number, approximately 69.5% involved an opioid, making it a leading cause of death in the United States. Additionally concerning is… read more here.
Keywords: individual counseling; treatment opioid; opioid use; treatment ... See more keywords
Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settings.
Sign Up to like & getrecommendations! Published in 2021 at "Addiction"
DOI: 10.1111/add.15627
Abstract: BACKGROUND AND AIMS Opioid agonist treatment is effective but resource intensive to administer safely in custodial settings, leading to significant under-treatment of opioid dependence in these settings worldwide. This study assessed the safety of subcutaneous… read more here.
Keywords: treatment; depot buprenorphine; treatment opioid; custodial settings ... See more keywords
Exploring psychological symptoms and associated factors in patients receiving medication-assisted treatment for opioid-use disorder
Sign Up to like & getrecommendations! Published in 2020 at "BJPsych Open"
DOI: 10.1192/bjo.2019.99
Abstract: Background Patients receiving treatment for opioid-use disorder (OUD) may experience psychological symptoms without meeting full criteria for psychiatric disorders. The impact of these symptoms on treatment outcomes is unclear. Aims To determine the prevalence of… read more here.
Keywords: use; psychological symptoms; treatment; patients receiving ... See more keywords
Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014-17
Sign Up to like & getrecommendations! Published in 2019 at "PLoS ONE"
DOI: 10.1371/journal.pone.0226349
Abstract: Background Access to adequate treatment for opioid use disorder (OUD) has been a high priority among American policymakers. Elucidation of the sociodemographic and institutional differences associated with the use, or lack thereof, of opioid agonist… read more here.
Keywords: enter treatment; treatment; time; treatment opioid ... See more keywords
The Individualized Treatment of Opioid Use Disorder.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of managed care & specialty pharmacy"
DOI: 10.18553/jmcp.2019.25.6.634
Abstract: DISCLOSURES No outside funding supported the writing of this commentary. Boyett is Chief Medical Officer and founder of the medical division of Pathway Healthcare, which provides treatment for opioid and other drug addictions. read more here.
Keywords: individualized treatment; treatment; opioid use; treatment opioid ... See more keywords